Product image of Linezolid Panmedica (Linezolid) supplied by GNH India

Linezolid Panmedica

Active Ingredient:
Linezolid
Origin:
EU

Linezolid Panmedica (Linezolid)

Linezolid, the active ingredient in Linezolid Panmedica, is an oxazolidinone antibiotic presented as an injectable solution for intravenous use. It is employed to treat serious infections caused by resistant Gram‑positive bacteria, including MRSA and VRE, in hospital and community settings.

GNH India supplies Linezolid Panmedica as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Panmedica

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Linezolid is indicated for infections caused by resistant Gram‑positive organisms and is used across several clinical pathways.

  • Methicillin‑resistant Staphylococcus aureus (MRSA) infections: provides effective bacterial eradication in resistant cases.
  • Vancomycin‑resistant Enterococcus (VRE) infections: offers an alternative treatment option when vancomycin fails.
  • Community‑acquired and hospital‑acquired pneumonia: targets the causative pathogens and improves respiratory outcomes.
  • Skin and soft tissue infections: reduces bacterial load and promotes healing in complicated skin infections.

How It Works

  • Linezolid inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing formation of the initiation complex. This action blocks the translation process, halting bacterial growth and leading to bacteriostatic activity against susceptible Gram‑positive organisms.

Side Effects

Linezolid may cause a range of adverse reactions, from mild to serious.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: loose stools that may be self‑limiting.
  • Headache: transient cranial discomfort.
  • Vomiting: occasional emesis.
  • Metallic taste: altered taste perception.
  • Rash: mild skin erythema.

Serious or Rare Side Effects

  • Thrombocytopenia: significant drop in platelet count.
  • Anemia: reduced red blood cell levels.
  • Peripheral neuropathy: nerve pain or tingling.
  • Serotonin syndrome: risk when combined with serotonergic agents.
  • Lactic acidosis: metabolic disturbance.
  • Optic neuropathy: visual disturbances requiring prompt evaluation.

Precautions & Warnings

When using Linezolid, clinicians should consider several safety measures.

  • Renal impairment: monitor renal function and adjust therapy as needed.
  • Hepatic impairment: assess liver enzymes regularly.
  • Concomitant serotonergic drugs: avoid due to risk of serotonin syndrome.
  • Prolonged therapy: conduct periodic complete blood counts.
  • Pregnancy: safety category unknown; weigh benefits against potential risks.
  • Store at ambient temperature: keep in original packaging, protect from moisture and light.

Avoid Interactions

Linezolid interacts with several drug classes; awareness of interaction severity guides clinical decisions.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): may precipitate hypertensive crisis.
  • Serotonergic agents (SSRIs, SNRIs, tramadol): risk of serotonin syndrome.
  • Rifampin: induces metabolism, reducing linezolid exposure.

Moderate Interactions (Monitor Closely)

  • Warfarin: may enhance anticoagulant effect, monitor INR.
  • Phenytoin: may lower linezolid levels, adjust monitoring.
  • Carbamazepine: potential reduction in efficacy, observe clinical response.

Frequently Asked Questions

Linezolid Panmedica is employed to treat serious infections caused by resistant Gram‑positive bacteria, including methicillin‑resistant Staphylococcus aureus (MRSA), vancomycin‑resistant Enterococcus (VRE), community‑acquired and hospital‑acquired pneumonia, and complicated skin and soft tissue infections.

Linezolid binds to the bacterial 50S ribosomal subunit, blocking the formation of the initiation complex required for protein synthesis. This inhibition halts bacterial growth, providing a bacteriostatic effect against susceptible Gram‑positive organisms.

The dosing regimen for Linezolid Panmedica is determined by the prescribing clinician based on the infection type, severity, patient weight, renal and hepatic function, and local guidelines. Healthcare professionals should follow the specific prescription instructions provided.

Linezolid is classified as having an unknown safety profile in pregnancy, and limited data exist for lactation. Clinicians should evaluate the potential benefits against possible risks and consider alternative therapies when safer options are available.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details, and necessary import documentation.

Linezolid and vancomycin both target Gram‑positive infections, but linezolid is an oral and intravenous oxazolidinone with activity against some vancomycin‑resistant strains, while vancomycin is a glycopeptide primarily given intravenously. Linezolid offers a convenient dosing schedule and penetrates lung tissue well, whereas vancomycin requires therapeutic drug monitoring.

Linezolid Panmedica should be stored at ambient temperature, below 25 °C, in its original container. Protect the product from moisture, direct sunlight, and extreme temperature fluctuations to maintain stability.

Linezolid Panmedica is supplied as an injectable solution for intravenous infusion. Administration is performed by a qualified healthcare professional, typically over a period of 30‑60 minutes, following aseptic technique and institutional infusion protocols.

Serious risks include thrombocytopenia, anemia, peripheral neuropathy, serotonin syndrome when combined with serotonergic drugs, lactic acidosis, and optic neuropathy. Patients should be monitored regularly for hematologic changes and neurological symptoms, and any concerning signs should prompt immediate medical evaluation.

Linezolid is contraindicated in patients with known hypersensitivity to linezolid or any component of the formulation. It should also be avoided in individuals currently taking monoamine oxidase inhibitors or serotonergic agents due to the risk of severe drug interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Linezolid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT